Irritable Bowel Syndrome Treatment Market Insights Growth Opportunities and Forecast to 2027

The growth of the market is driven by the factors such as, increasing prevalence of irritable bowel syndrome and associated conditions, and increasing numbers of FDA approvals & drug developments. On the other hand, limited number of product availability and treatment inefficiency is likely to restraint the growth of market during the forecast years.

Irritable Bowel Syndrome is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping.

Register for a free Trial today and gain instant*access @ Click Here

Top Dominating Key Players:

  1. Ironwood Pharmaceuticals, Inc.
  2. Allergan Plc.
  3. Sebela Pharmaceuticals, Inc.
  4. Takeda Pharmaceutical Company Limited
  5. Alfasigma S.p.A.
  6. Astellas Pharma Inc.
  7. AstraZeneca
  8. Synthetic Biologics, Inc.
  9. Bausch + Lomb Incorporated
  10. Lannett Company Inc.

Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. According to data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients about 40% of people have mild IBS, around 35% have moderate IBS, and an estimated have 25% severe IBS. Many people don't recognize IBS symptoms. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are some of the risk factors which are causing irritable bowel syndrome.

These factors are projected to accelerate the rate of prevalence of irritable bowel syndrome across the globe. For instance, according to a study published on NCBI in 2018, irritable bowel syndrome is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of irritable bowel syndrome is likely to boost the US irritable bowel syndrome treatment market during the forecast period.

Purchase for Report @ https://bit.ly/2V8PsCz

Key Benefits:

  • This report provides a detailed study of market trends and forecast from 2019 to 2025, which assist to identify the prevailing market opportunities.
  • In-depth coverage of the global market that includes drivers, restraints, and opportunities, helps professionals to understand the market behavior in a better way.
  • Detailed study of the strategies of key leaders, partnerships, and acquisitions in the market is provided.

Source : Business Market Insights

Comments

Popular posts from this blog

News & Trends Impacting the Healthcare Supply Chain

How Chatbots and AI are Changing the Healthcare Industry

Next Generation Sequencing Market Demand, Supply, Growth Factors, Latest Rising Trend & Forecast to 2025